Cisen Pharmaceutical Co., Ltd. (SHA:603367)

Cisen Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,669	6,221	6,601	5,668	5,978	6,229
Market Cap Growth	-4.20%	-5.76%	16.46%	-5.19%	-4.03%	-16.98%
Enterprise Value	10,978	3,782	4,082	3,364	3,917	3,923
Last Close Price	30.19	13.53	13.77	11.59	11.98	12.22
PE Ratio	27.96	12.22	12.66	16.20	17.89	14.20
Forward PE	-	46.95	46.95	46.95	46.95	46.95
PS Ratio	3.64	1.56	1.48	1.39	1.58	1.70
PB Ratio	2.23	1.04	1.15	1.06	1.18	1.30
P/TBV Ratio	2.32	1.08	1.20	1.11	1.23	1.36
P/FCF Ratio	46.25	13.26	15.23	25.40	32.74	27.23
P/OCF Ratio	35.66	10.90	14.63	21.94	25.59	14.45
EV/Sales Ratio	2.93	0.95	0.92	0.83	1.03	1.07
EV/EBITDA Ratio	16.79	5.53	5.22	6.47	9.07	7.58
EV/EBIT Ratio	25.01	8.10	7.41	11.55	18.28	10.96
EV/FCF Ratio	37.14	8.06	9.41	15.08	21.45	17.15
Debt / Equity Ratio	0.00	0.02	0.03	0.03	0.03	0.07
Debt / EBITDA Ratio	0.04	0.17	0.22	0.30	0.33	0.64
Debt / FCF Ratio	0.08	0.25	0.39	0.71	0.79	1.44
Asset Turnover	0.50	0.54	0.63	0.62	0.60	0.63
Inventory Turnover	2.38	2.39	2.97	3.11	2.96	2.75
Quick Ratio	2.81	2.72	3.02	3.17	2.86	2.56
Current Ratio	3.54	3.33	3.63	3.70	3.40	3.08
Return on Equity (ROE)	8.24%	8.76%	9.45%	6.77%	6.78%	9.33%
Return on Assets (ROA)	3.62%	3.92%	4.87%	2.76%	2.14%	3.82%
Return on Capital (ROIC)	4.46%	4.85%	6.01%	3.40%	2.59%	4.56%
Return on Capital Employed (ROCE)	7.10%	7.70%	9.20%	5.30%	4.20%	7.30%
Earnings Yield	3.58%	8.18%	7.90%	6.17%	5.59%	7.04%
FCF Yield	2.16%	7.54%	6.57%	3.94%	3.05%	3.67%
Dividend Yield	1.47%	3.25%	3.16%	2.89%	2.50%	2.09%
Payout Ratio	61.96%	59.85%	29.95%	39.87%	36.13%	63.81%
Buyback Yield / Dilution	-0.35%	-0.23%	0.25%	-0.65%	0.18%	-0.21%
Total Shareholder Return	1.12%	3.02%	3.42%	2.24%	2.68%	1.88%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.